Polymicrobial intensive care unit-acquired pneumonia: Prevalence, microbiology and outcome

Critical Care

Volumn 19, Issue 1, 2015, Pages

  Ferrer, Miquel ^a,b,c   Difrancesco, Leonardo Filippo ^a,d   Liapikou, Adamantia ^a,e   Rinaudo, Mariano ^a   Carbonara, Marco ^a,f   Li Bassi, Gianluigi ^a,b,c   Gabarrus, Albert ^a,b   Torres, Antoni ^a,b,c  

^a HOSPITAL CLÍNIC   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e SOTIRIA GENERAL HOSPITAL   (Greece)

^f UNIVERSITY OF MILAN   (Italy)

Author keywords

Hospital acquired pneumonia; ICU acquired pneumonia; Polymicrobial pneumonia; Ventilator acquired pneumonia

Indexed keywords

ADRENOMEDULLIN; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CORTICOSTEROID; INTERLEUKIN 6; INTERLEUKIN 8; PROCALCITONIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ALPHA HEMOLYTIC STREPTOCOCCUS; APACHE; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; CANDIDA; CONTROLLED STUDY; CORYNEBACTERIUM; ENTEROBACTERIACEAE; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; INFECTIOUS PNEUMONIA; INTENSIVE CARE UNIT ACQUIRED PNEUMONIA; LENGTH OF STAY; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEISSERIA; OUTCOME ASSESSMENT; PLEURA EFFUSION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SEPTIC SHOCK; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; AGED; COINFECTION; CROSS INFECTION; IATROGENIC DISEASE; INTENSIVE CARE UNIT; MICROBIOLOGY; MIDDLE AGED; PNEUMONIA; TRANSMISSION;

ADULT; AGED; COINFECTION; CROSS INFECTION; FEMALE; HUMANS; IATROGENIC DISEASE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PNEUMONIA; PREVALENCE; PROSPECTIVE STUDIES;

EID: 84951840553     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-015-1165-5     Document Type: Article

References (39)

1. American Thoracic Society, Infectious Diseases Society Of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388-416.
2. Esperatti M, Ferrer M, Theessen A, Liapikou A, Valencia M, Saucedo LM, et al. Nosocomial pneumonia in the intensive care unit acquired during mechanical ventilation or not. Am J Respir Crit Care Med. 2010;182:1533-9.
3. Burgmann H, Hiesmayr JM, Savey A, Bauer P, Metnitz B, Metnitz PP. Impact of nosocomial infections on clinical outcome and resource consumption in critically ill patients. Intensive Care Med. 2010;36:1597-601.
4. Wg M, Mm R, Groenwold R, Dc B, Camus C, Bauer TT, et al. Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies. Lancet Infect Dis. 2013;13:665-71.
5. Alvarez-Lerma F. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group. Intensive Care Med. 1996;22:387-94.
6. Ms N, Soulountsi V. De-escalation therapy: is it valuable for the management of ventilator-associated pneumonia? Clin Chest Med. 2011;32:517-34.
7. Kumar A, Zarychanski R, Light B, Parrillo J, Maki D, Simon D, et al. Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis. Crit Care Med. 2010;38:1773-85.
8. Dk H, Dodek P, Muscedere J, Day A, Cook D. Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia. Crit Care Med. 2008;36:737-44.
9. Di Pasquale M, Ferrer M, Esperatti M, Crisafulli E, Giunta V, Li Bassi G, et al. Assessment of severity of ICU-acquired pneumonia and association with etiology. Crit Care Med. 2014;42:303-12.
10. Blot S, Koulenti D, Dimopoulos G, Martin C, Komnos A, Krueger WA, et al. Prevalence, risk factors, and mortality for ventilator-associated pneumonia in middle-aged, old, and very old critically ill patients * . Crit Care Med. 2014;42:601-9.
11. Combes A, Figliolini C, Trouillet JL, Kassis N, Wolff M, Gibert C, et al. Incidence and outcome of polymicrobial ventilator-associated pneumonia. Chest. 2002;121:1618-23.
12. Kohlenberg A, Schwab F, Behnke M, Geffers C, Gastmeier P. Pneumonia associated with invasive and noninvasive ventilation: an analysis of the german nosocomial infection surveillance system database. Intensive Care Med. 2010;36:971-8.
13. Karhu J, Ala-Kokko TI, Ylipalosaari P, Ohtonen P, Laurila JJ, Syrjala H. Hospital and long-term outcomes of ICU-treated severe community- and hospital-acquired, and ventilator-associated pneumonia patients. Acta Anaesthesiol Scand. 2011;55:1254-60.
14. Giunta V, Ferrer M, Esperatti M, Ranzani O, Saucedo LM, Bassi GL, et al. ICU-acquired pneumonia with or without etiologic diagnosis: a comparison of outcomes. Crit Care Med. 2013;41:2133-43.
15. Fabregas N, Ewig S, Torres A, El Ebiary M, Ramirez J, De La Bellacasa JP, et al. Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax. 1999;54:867-73.
16. Woodhead MA, Torres A. Definition and Classification of Community-Acquired and Nosocomial Pneumonias. In: Torres A, Woodhead M, editors. Pneumonia. Sheffield: European Respiratory Society Journals Ltd; 1997. p. 1-12.
17. Meduri GU, Chastre J. The standardization of bronchoscopic techniques for ventilator-associated pneumonia. Chest. 1992;102:557s-64.
18. Kollef M, Kr B, Rd R, Ml H. The safety and diagnosis accuracy of minibronchoalveolar lavage in patients with suspected ventilator associated pneumonia. Ann Intern Med. 1995;122:743-8.
19. Ruiz M, Torres A, Ewig S, Marcos MA, Alcón A, Lledó R, et al. Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia: evaluation of outcome. Am J Respir Crit Care Med. 2000;162:119-25.
20. Ioanas M, Cavalcanti M, Ferrer M, Valencia M, Agusti C, Puig De La Bellacasa J, et al. Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines. Eur Respir J. 2003;22:876-82.
21. Am V, Ma T, Oj I, Lf A, Jn C, Cm H, et al. Diagnostic value of quantitative cultures of endotracheal aspirate in ventilator-associated pneumonia: a multicenter study. Arch Bronconeumol. 2003;39:394-9.
22. Martin-Loeches I, Torres A, Rinaudo M, Terraneo S, De Rosa F, Ramirez P, et al. Resistance patterns and outcomes in intensive care unit (ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organisms. J Infect. 2015;70:213-22.
23. Ioanas M, Ferrer M, Cavalcanti M, Ferrer R, Ewig S, Filella X, et al. Causes and predictors of non-response to treatment of the icu-acquired pneumonia. Crit Care Med. 2004;32:938-45.
24. Esperatti M, Ferrer M, Giunta V, Ranzani O, Saucedo LM, Li Bassi G, et al. Validation of predictors of adverse outcomes in hospital-acquired pneumonia in the ICU*. Crit Care Med. 2013;41:2151-61.
25. Ramirez P, Ferrer M, Marti V, Reyes S, Martinez R, Menendez R, et al. Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia. Crit Care Med. 2011;39:2211-7.
26. Bello S, Lasierra AB, Minchole E, Fandos S, Ruiz M, Vera E, et al. Prognostic power of proadrenomedullin in community-acquired pneumonia is independent of aetiology. Eur Respir J. 2012;39:1144-55.
27. Wa K, Ea D, Dp W, Je Z. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818-29.
28. Gall Jr L, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270:2957-63.
29. Cm L, Blanzaco D, Niederman MS, Matarucco W, Baredes NC, Desmery P, et al. Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit Care Med. 2003;31:676-82.
30. Jl V, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707-10.
31. Rp D, Mm L, Jm C, Bion J, Parker MM, Jaeschke R, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36:296-327.
32. Vm R, Gd R, Thompson B, Nd F, Caldwell E, Fan E, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307:2526-33.
33. Da S, Gr B. Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome. Crit Care Med. 2002;30:1772-7.
34. Jy F, Chastre J, Domart Y, Trouillet JL, Pierre J, Darne C, et al. Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques. Am Rev Respir Dis. 1989;139:877-84.
35. Jj R, Martin De Lassale E, Poete P, Nicolas MH, Bodin L, Jarvier V, et al. Nosocomial bronchopneumonia in the critically ill: Histologic and bacteriologic aspects. Am Rev Respir Dis. 1992;146:1059-66.
36. Jimenez P, Torres A, Rodriguez RR, De-La-Bellacasa JP, Aznar R, Gatell JM, et al. Incidence and etiology of pneumonia acquired during mechanical ventilation. Crit Care Med. 1989;17:882-5.
37. Jl T, Chastre J, Vuagnat A, Joly-Guillou ML, Combaux D, Dombret MC, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med. 1998;157:531-9.
38. Papazian L, Bregeon F, Thirion X, Gregoire R, Saux P, Denis JP, et al. Effect of ventilator-associated pneumonia on mortality and morbidity. Am J Respir Crit Care Med. 1996;154:91-7.
39. Ewig S, Torres A, Angeles MM, Angrill J, Rano A, De Roux A, et al. Factors associated with unknown aetiology in patients with community-acquired pneumonia. Eur Respir J. 2002;20:1254-62.